Evidence map›Paper›PMID 32411013›Full record

ReviewFrontiers in physiology2020

Cardioprotective Role of Melatonin in Acute Myocardial Infarction.

Zhenhong Fu, Yang Jiao, Jihang Wang, Ying Zhang, Mingzhi Shen, Russel J Reiter, Qing Xi, Yundai Chen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. The Protective Effect of Melatonin on LPS-Induced Myocardial InjuryCombinatorial chemistry & high throughput screening · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Myocardial Infarction Susceptibility and theInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Zhenhong FuDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Yang JiaoDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jihang WangDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Ying ZhangDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Mingzhi ShenDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Russel J ReiterDepartment of Cellular and Structural Biology, UT Health San Antonio, San Antonio, TX, United States.
Qing XiThe First Medical Center, Chinese PLA General Hospital, Beijing, China.
Yundai ChenDepartment of Cardiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNThe University of Texas at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a pleiotropic, indole secreted, and synthesized by the human pineal gland. Melatonin has biological effects including anti-apoptosis, protecting mitochondria, anti-oxidation, anti-inflammation, and stimulating target cells to secrete cytokines. Its protective effect on cardiomyocytes in acute myocardial infarction (AMI) has caused widespread interest in the actions of this molecule. The effects of melatonin against oxidative stress, promoting autophagic repair of cells, regulating immune and inflammatory responses, enhancing mitochondrial function, and relieving endoplasmic reticulum stress, play crucial roles in protecting cardiomyocytes from infarction. Mitochondrial apoptosis and dysfunction are common occurrence in cardiomyocyte injury after myocardial infarction. This review focuses on the targets of melatonin in protecting cardiomyocytes in AMI, the main molecular signaling pathways that melatonin influences in its endogenous protective role in myocardial infarction, and the developmental prospect of melatonin in myocardial infarction treatment.

Indexed as

cardiomyocytecardioprotectivemelatoninmitochondrionmyocardial infarction

Identifiers

PMID32411013
PMCPMC7201093
OpenAlexW3023648742

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.